GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Prism Biolab Co Ltd (TSE:206A) » Definitions » LT-Debt-to-Total-Asset

Prism Biolab Co (TSE:206A) LT-Debt-to-Total-Asset : 0.00 (As of Sep. 2024)


View and export this data going back to 2024. Start your Free Trial

What is Prism Biolab Co LT-Debt-to-Total-Asset?

LT Debt to Total Assets is a measurement representing the percentage of a corporation's assets that are financed with loans and financial obligations lasting more than one year. The ratio provides a general measure of the financial position of a company, including its ability to meet financial requirements for outstanding loans. It is calculated as a company's Long-Term Debt & Capital Lease Obligationdivide by its Total Assets. Prism Biolab Co's long-term debt to total assests ratio for the quarter that ended in Sep. 2024 was 0.00.

Prism Biolab Co's long-term debt to total assets ratio stayed the same from Sep. 2023 (0.00) to Sep. 2024 (0.00).

Prism Biolab Co LT-Debt-to-Total-Asset Historical Data

The historical data trend for Prism Biolab Co's LT-Debt-to-Total-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Prism Biolab Co LT-Debt-to-Total-Asset Chart

Prism Biolab Co Annual Data
Trend Sep22 Sep23 Sep24
LT-Debt-to-Total-Asset
- - -

Prism Biolab Co Semi-Annual Data
Sep22 Sep23 Mar24 Sep24
LT-Debt-to-Total-Asset - - - -

Prism Biolab Co LT-Debt-to-Total-Asset Calculation

Prism Biolab Co's Long-Term Debt to Total Asset Ratio for the fiscal year that ended in Sep. 2024 is calculated as

LT Debt to Total Assets (A: Sep. 2024 )=Long-Term Debt & Capital Lease Obligation (A: Sep. 2024 )/Total Assets (A: Sep. 2024 )
=0/4528.566
=0.00

Prism Biolab Co's Long-Term Debt to Total Asset Ratio for the quarter that ended in Sep. 2024 is calculated as

LT Debt to Total Assets (Q: Sep. 2024 )=Long-Term Debt & Capital Lease Obligation (Q: Sep. 2024 )/Total Assets (Q: Sep. 2024 )
=0/4528.566
=0.00

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Prism Biolab Co  (TSE:206A) LT-Debt-to-Total-Asset Explanation

LT Debt to Total Asset is a measurement representing the percentage of a corporation's assets that are financed with loans and financial obligations lasting more than one year. The ratio provides a general measure of the financial position of a company, including its ability to meet financial requirements for outstanding loans. A year-over-year decrease in this metric would suggest the company is progressively becoming less dependent on debt to grow their business.

Prism Biolab Co LT-Debt-to-Total-Asset Related Terms

Thank you for viewing the detailed overview of Prism Biolab Co's LT-Debt-to-Total-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.

Prism Biolab Co Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Prism Biolab Co Ltd (TSE:206A) » Definitions » LT-Debt-to-Total-Asset
Comparable Companies
TSE:4896 TSE:4583 TSE:4571 TSE:2370 TSE:177A TSE:4579 TSE:4564 TSE:2183 TSE:3750 TSE:4893 VRTX ASX:CSL REGN XKRX:207940 XBRU:ARGX ALNY XBRU:UCB ONC XKRX:068270 BNTX
Traded in Other Exchanges
N/A
Address
2-26-1 Muraokahigashi, Kanagawa, Fujisawa, JPN, 251-8555
Website
https://www.prismbiolab.com
Prism Biolab Co Ltd is engaged in drug discovery and development based on PepMetics Technology, a proprietary platform technology.

Prism Biolab Co Headlines

No Headlines